ReviewFrontiers in immunology2026
Comparative analysis of placental transmission mechanisms for Dengue and Zika viruses: outcomes and future directions.
Review in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Zika and Dengue viruses are arboviral pathogens capable of crossing the placental barrier, representing major global health risks for maternal and fetal outcomes. In this narrative review, we compare their epidemiology, clinical consequences in pregnancy, and underlying mechanisms of vertical transmission. Emerging molecular insights are highlighted, including disruptions to placental signaling pathways such as JAK/STAT and mTOR, and strategies to evade Hofbauer cells and the immune system. A comparative analysis of these processes underscores a critical need for improved understanding of placental pathophysiology, immune regulation, and molecular pathways of transmission. Identifying such mechanisms may promote vaccine development, improved diagnostics, and therapies to reduce adverse outcomes in the mother-infant dyad during maternal infection.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.